Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
CorMedix Inc. is a US-based biopharmaceutical company specializing in the development and commercialization of therapeutic products for infection prevention. The company focuses on innovative medical solutions, with a particular emphasis on addressing the needs of patients using central venous catheters.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
CorMedix is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
CorMedix last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at 0.29 USD.
CorMedix has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.